We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

L’Oreal Allowed To Market Reconstructed Skin Tissue In China

September 29, 2014: 12:00 AM EST
L'Oréal was granted a business license in China that will allow it to market its reconstructed Asian skin models through Shanghai Episkin Biotechnology. L'Oréal began producing reconstructed skin in 2008, using several different technologies that rebuild human epidermis tissue from Asian keratinocytes. The reconstructed skin is used to test cosmetic products and ingredients for safety, eliminating the need for animal testing. The Chinese Episkin model is produced by the L’Oréal Advanced Research laboratories in China.
"L’Oreal Obtains A Business License For Reconstructed Skin Models Episkin In China", News release, L’Oréal , September 29, 2014, © L’Oréal
Domains
Innovation
Collaboration & Networks
Sectors
Personal Care
Geographies
Worldwide
EMEA
Asia-Pacific
Europe
China
France
Categories
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Press Release
Developed by Yuri Ingultsov Software Lab.